Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Generalizability of results from the national lung screening trial
Marlies E. Heuvers
, Juan Wisnivesky
, Bruno H. Stricker
, Joachim G. Aerts
Research output
:
Contribution to journal
›
Article
›
peer-review
25
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Generalizability of results from the national lung screening trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung Cancer
100%
National Lung Screening Trial
100%
Computed Tomographic
75%
Clinical Practice
50%
Better Prognosis
25%
5-year Survival
25%
Disease Diagnosis
25%
Treatment Options
25%
Smokers
25%
High-risk Population
25%
Total Population
25%
Reduced Mortality
25%
Cancer Cases
25%
Life Expectancy
25%
Chest Radiography
25%
Early Diagnosis
25%
Lung Cancer Screening
25%
Ethical Considerations
25%
Prolonged Life
25%
Cancer Death Rates
25%
Medicine and Dentistry
Lung Cancer
100%
National Lung Screening Trial
100%
Health Care Cost
25%
Low Drug Dose
25%
Thorax Radiography
25%
Clinician
25%
Cancer Mortality
25%
Mortality Rate
25%
High Risk Population
25%
Life Expectancy
25%
Early Diagnosis
25%
Overdiagnosis
25%
Lung Cancer Screening
25%
Diseases
25%
Treatment Option
25%
Nursing and Health Professions
Lung Cancer
100%
Clinical Practice
40%
Low Drug Dose
20%
Mortality Rate
20%
High Risk Population
20%
Life Expectancy
20%
Early Diagnosis
20%
Cancer Mortality
20%
Thorax Radiography
20%
Cancer Screening
20%
Diseases
20%
Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Mortality Rate
20%
Cancer Mortality
20%
Life Expectancy
20%
Diseases
20%
Veterinary Science and Veterinary Medicine
Lung Cancer
100%
Thorax Radiography
20%
Diseases
20%